Summary
Cell Therapy Catapult Ltd(Catapult), d/b/a Cell and Gene Therapy Catapult, is a biotechnology company that develops, delivers and commercializes cell and gene therapies. The company helps cell and gene therapy companies worldwide to translate early stage research into commercially sustainable and investable treatments. It offers non-clinical safety, clinical trials, regulation, market access, assay development, process development and manufacturing services. It works with a range of cell therapy models that include T cells, hESCs or iPSCs, MSCs, neural, cardiac and bone marrow derived stem cells and primary tissue derived somatic cells. Catapult is supported by Innovate UK. The company’s partner portfolio includes Intercytex Ltd, ReNeuron, GlaxoSmithKline, Roslin Cells and others. Catapult is headquartered in London, England, the UK.
Cell Therapy Catapult Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cell Therapy Catapult Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 12
Cell Therapy Catapult Enters into Agreement with CRC for Cell Therapy Manufacturing 12
Cell Therapy Catapult Enters into partnership with Cooperative Research Centre for Cell Therapy Manufacturing 13
Cell Therapy Catapult Forms Joint Venture with University of Aberdeen 14
Synpromics Enters into Agreement with Cell Therapy Catapult 15
Cell Therapy Catapult Enters into Joint venture Agreement with University of Birmingham and Cancer Research Technology 15
Asterias Biotherapeutics Enters into Agreement with Cell Therapy Catapult 16
Cell Therapy Catapult Enters into Agreement with Asymptote 17
Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement 18
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 19
Cell Therapy Catapult, Azellon, University of Liverpool and NHS Blood and Transplant Enter into Agreement 20
Cell Therapy Catapult Enters into Agreement with Athersys 20
Cell Therapy Catapult Enters into Research Agreement with TrakCel 21
Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations 22
ReNeuron Enters Into Co-Development Agreement With Cell Therapy Catapult 23
Licensing Agreements 24
Cell Therapy Catapult Enters into Licensing Agreement with iPS Academia Japan 24
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cell Therapy Catapult Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Cell Therapy Catapult Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 12
Cell Therapy Catapult Enters into Agreement with CRC for Cell Therapy Manufacturing 12
Cell Therapy Catapult Enters into partnership with Cooperative Research Centre for Cell Therapy Manufacturing 13
Cell Therapy Catapult Forms Joint Venture with University of Aberdeen 14
Synpromics Enters into Agreement with Cell Therapy Catapult 15
Cell Therapy Catapult Enters into Joint venture Agreement with University of Birmingham and Cancer Research Technology 15
Asterias Biotherapeutics Enters into Agreement with Cell Therapy Catapult 16
Cell Therapy Catapult Enters into Agreement with Asymptote 17
Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement 18
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 19
Cell Therapy Catapult, Azellon, University of Liverpool and NHS Blood and Transplant Enter into Agreement 20
Cell Therapy Catapult Enters into Agreement with Athersys 20
Cell Therapy Catapult Enters into Research Agreement with TrakCel 21
Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations 22
ReNeuron Enters Into Co-Development Agreement With Cell Therapy Catapult 23
Cell Therapy Catapult Enters into Licensing Agreement with iPS Academia Japan 24
Cell Therapy Catapult Ltd, Key Employees 26
List of Figures
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cell Therapy Catapult Ltd, Medical Devices Deals, 2011 to YTD 2017 9
